Literature DB >> 3592788

Synovial accumulation of technetium labelled liposomes in rheumatoid arthritis.

B D Williams, M M O'Sullivan, G S Saggu, K E Williams, L A Williams, J R Morgan.   

Abstract

Technetium labelled, negatively charged, unilamellar liposomes were given by intravenous injection to patients with rheumatoid arthritis and the joints scanned 20-22 hours later. Positive scintigraphy was obtained in all six patients with active disease, and, with the exception of the small interphalangeal joints, all clinically involved joints could be visualised.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3592788      PMCID： PMC1002126          DOI： 10.1136/ard.46.4.314

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  11 in total

1.  Selective concentration and localization of gold in macrophages of synovial and other tissues during and after chrysotherapy in rheumatoid patients.

Authors:  B Vernon-Roberts; J L Doré; J D Jessop; W J Henderson
Journal:  Ann Rheum Dis       Date:  1976-12       Impact factor: 19.103

2.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

3.  Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.

Authors:  C R Alving; E A Steck; W L Chapman; V B Waits; L D Hendricks; G M Swartz; W L Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

4.  The carrier potential of liposomes in biology and medicine (first of two parts).

Authors:  G Gregoriadis
Journal:  N Engl J Med       Date:  1976-09-23       Impact factor: 91.245

5.  Properties of [99mTc] technetium-labelled liposomes in normal and tumour-bearing rats.

Authors:  V J Richardson; K Jeyasingh; R F Jewkes; B E Ryman; M H Tattersall
Journal:  Biochem Soc Trans       Date:  1977       Impact factor: 5.407

6.  Liposomes: a new approach to gold therapy?

Authors:  L G Cleland; M Shandling; J S Percy; M J Poznansky
Journal:  J Rheumatol Suppl       Date:  1979

7.  Technetium-labelled liposome imaging for deep-seated infection.

Authors:  J R Morgan; L A Williams; C B Howard
Journal:  Br J Radiol       Date:  1985-01       Impact factor: 3.039

8.  Clinical pharmacology of 99mTc-labeled liposomes in patients with cancer.

Authors:  G Lopez-Berestein; L Kasi; M G Rosenblum; T Haynie; M Jahns; H Glenn; R Mehta; G M Mavligit; E M Hersh
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

9.  Indium-111-labelled leucocytes for localisation of abscesses.

Authors:  A W Segal; R N Arnot; M L Thakur; J P Lavender
Journal:  Lancet       Date:  1976-11-13       Impact factor: 79.321

10.  Localisation of experimental staphylococcal abscesses by 99MTC-technetium-labelled liposomes.

Authors:  J R Morgan; K E Williams; R L Davies; K Leach; M Thomson; L A Williams
Journal:  J Med Microbiol       Date:  1981-05       Impact factor: 2.472
View more
  10 in total

1.  Technetium-99m labelled liposomes to image experimental arthritis.

Authors:  O C Boerman; W J Oyen; G Storm; M L Corvo; L van Bloois; J W van der Meer; F H Corstens
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

2.  Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis.

Authors:  W G Love; N Amos; I W Kellaway; B D Williams
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

3.  Specific accumulation of technetium-99m radiolabelled, negative liposomes in the inflamed paws of rats with adjuvant induced arthritis: effect of liposome size.

Authors:  W G Love; N Amos; I W Kellaway; B D Williams
Journal:  Ann Rheum Dis       Date:  1989-02       Impact factor: 19.103

4.  Interleukin-1beta (IL-1beta) inhibition: a possible mechanism for the anti-inflammatory potency of liposomally conjugated methotrexate formulations in arthritis.

Authors:  A S Williams; S G Jones; R M Goodfellow; N Amos; B D Williams
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

Review 5.  Biopharmaceutical aspects of lipid formulations of amphotericin B.

Authors:  G Storm; E van Etten
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-01       Impact factor: 3.267

6.  The effect of free and liposome-encapsulated clodronate on the hepatic mononuclear phagocyte system in the rat.

Authors:  J P Camilleri; A S Williams; N Amos; A G Douglas-Jones; W G Love; B D Williams
Journal:  Clin Exp Immunol       Date:  1995-02       Impact factor: 4.330

7.  Methods for assessing splenic macrophage depletion by liposome encapsulated clodronate.

Authors:  J P Camilleri; A S Williams; N Amos; A G Douglas-Jones; W G Love; B D Williams
Journal:  Inflamm Res       Date:  1995-04       Impact factor: 4.575

8.  Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids.

Authors:  Yuval Avnir; Keren Turjeman; Deborah Tulchinsky; Alex Sigal; Pablo Kizelsztein; Dina Tzemach; Alberto Gabizon; Yechezkel Barenholz
Journal:  PLoS One       Date:  2011-10-06       Impact factor: 3.240

Review 9.  Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine.

Authors:  Francis Man; Peter J Gawne; Rafael T M de Rosales
Journal:  Adv Drug Deliv Rev       Date:  2019-06-03       Impact factor: 15.470

10.  Alpha-methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy.

Authors:  Jungyeon Hwang; Kathleen Rodgers; James C Oliver; Thomas Schluep
Journal:  Int J Nanomedicine       Date:  2008
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.